H.R.1919 - Bleeding Disorder Screening, Awareness, and Further Education (SAFE) Act of 2011112th Congress (2011-2012)
|Sponsor:||Rep. McCarthy, Carolyn [D-NY-4] (Introduced 05/13/2011)|
|Committees:||House - Energy and Commerce|
|Latest Action:||05/23/2011 Referred to the Subcommittee on Health. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: H.R.1919 — 112th Congress (2011-2012)All Bill Information (Except Text)
Introduced in House (05/13/2011)
Bleeding Disorder Screening, Awareness, and Further Education (SAFE) Act of 2011 - Requires the Secretary of Health and Human Services (HHS) to take specified action, directly or through a grant program, with respect to blood disorders in adolescents, including: (1) developing a new, or identifying an existing, screening questionnaire that is evidence-based and in accordance with clinical guidelines for use in the diagnosis of bleeding disorders in adolescents and young adults; (2) disseminating and implementing the screening questionnaire and other screening tools relevant to the diagnosis of bleeding disorders in adolescents; (3) ensuring referral for further laboratory-based diagnostic testing if screening suggests the possibility of a bleeding disorder; and (4) ensuring referral for medical management if laboratory testing confirms diagnosis of a bleeding disorder.
Requires the Secretary to conduct an education campaign to increase awareness about bleeding disorders among health professionals.
Requires the the Director of the Centers for Disease Control and Prevention (CDC) to award grants or contracts to public or nonprofit private entities to: (1) augment existing research efforts to evaluate, improve, and standardize methods for diagnosing bleeding disorders; and (2) expand ongoing efforts to determine the prevalence of bleeding disorders, identify symptoms, risk factors, and co-morbidities associated with bleeding disorders, and implement female-specific surveillance systems and conduct related research to improve bleeding symptoms and quality of life among adolescent and adult women with bleeding disorders.